Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Current Taxes: 2023-2024

Historic Current Taxes for Entrada Therapeutics (TRDA) over the last 2 years, with Dec 2024 value amounting to $667,000.

  • Entrada Therapeutics' Current Taxes fell 72.46% to $620,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $620,000, marking a year-over-year decrease of 72.46%. This contributed to the annual value of $667,000 for FY2024, which is 83.42% down from last year.
  • As of FY2024, Entrada Therapeutics' Current Taxes stood at $667,000, which was down 83.42% from $4.0 million recorded in FY2023.
  • Entrada Therapeutics' Current Taxes' 5-year high stood at $4.0 million during FY2023, with a 5-year trough of $667,000 in FY2024.
  • Its 2-year average for Current Taxes is $2.3 million, with a median of $2.3 million in 2023.
  • Data for Entrada Therapeutics' Current Taxes shows a maximum YoY slumped of 83.42% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Entrada Therapeutics' Current Taxes stood at $4.0 million in 2023, then slumped by 83.42% to $667,000 in 2024.